Scientists say their lab results could make their compound a promising drug for combating dementia, possibly also autism

Study of older adults in Argentina finds some have dementia-like changes in memory and thinking for at least six months after contracting coronavirus

Joshua Henkin's 'Morningside Heights' examines devastating emotional and physical ripple effects after a person loses ability to think, communicate and function before age of 65

Drug produced by Biogen said to be 'reasonably likely' to benefit Alzheimer's patients, despite warnings that treatment hasn’t been shown to help slow the brain-destroying disease

Research on SIRT6 protein finds that some DNA damage can be reversed using interventions such as calorie restriction

Scientists sequence RNA inside tissue ‘to nano resolution,’ and say breakthrough heralds new insights on brain research and why immunotherapy only works on some cancer patients

Research could launch revolution in treating degenerative disease, experts say, since current challenge is diagnosing it early enough

Toronto-based biomedical engineers Eliav Shaked and Roy Kirshon are working on a quick, non-invasive retinal diagnostic for patients decades away from showing symptoms of dementia

ImmunoBrain Checkpoint's antibody that boosts immune cells' communication with brain seen effective in lab animals; clinical trials in humans to start next year

Testing identifies people with disease with accuracy ranging from 89% to 98%, but scientists warn new approach still needs more validation